Cell-in-Cell: From Cell Biology to Translational Medicine.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2022
Historique:
received: 23 05 2022
revised: 26 07 2022
accepted: 21 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Cell-in-cell structures (CICs) refer to cytoplasmic internalization of a cell by another cell, which are found throughout various biological systems and have been a part of scientific dogma for a long time. However, neither the mechanisms underlying this phenomenon nor their possible roles in disease development have resulted in major breakthroughs until recent years. In view of the ubiquity of CICs in inflammatory tissue and tumors, it is tempting to think that these specific structures could be associated with clinical diagnosis and treatment and thus would become a new hotspot for translational medicine. Translational medicine is a new concept in the field of international biomedical research that appeared in the last 20 years, which transforms basic research into clinical application. With the growing interest in this field, this review addresses recent research on CICs and their potential clinical implications in cytomorphological diagnosis and the pathology of human diseases, while discussing as yet unanswered questions. We also put forward future directions to reduce the gap in our knowledge caused by our currently limited understanding of CICs.

Identifiants

pubmed: 36158876
doi: 10.1155/2022/7608521
pmc: PMC9492417
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7608521

Informations de copyright

Copyright © 2022 Qiao Chen et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Biomed Res Int. 2015;2015:359392
pubmed: 26504802
Signal Transduct Target Ther. 2020 Oct 20;5(1):246
pubmed: 33082315
Veroff Pathol. 1989;132:1-107
pubmed: 2524940
J Mol Cell Biol. 2021 Aug 18;13(5):329-334
pubmed: 33693765
Dev Cell. 2016 Sep 12;38(5):536-47
pubmed: 27623384
Cell Death Differ. 2021 Sep;28(9):2765-2777
pubmed: 33879858
Cell Res. 2014 Nov;24(11):1299-310
pubmed: 25342560
Cancer Med. 2019 Mar;8(3):1054-1065
pubmed: 30791221
Cell Death Dis. 2013 Oct 10;4:e856
pubmed: 24113190
Nat Commun. 2018 Aug 3;9(1):3070
pubmed: 30076358
Cell Res. 2015 Jul;25(7):785-800
pubmed: 25916549
Front Oncol. 2019 Dec 19;9:1444
pubmed: 31921689
Elife. 2014 Jun 20;3:
pubmed: 24950964
Sci Rep. 2015 Jul 20;5:12223
pubmed: 26192076
Lab Invest. 2003 Nov;83(11):1555-67
pubmed: 14615410
Front Immunol. 2020 May 13;11:650
pubmed: 32528462
J Cell Mol Med. 2020 Jan;24(2):1268-1275
pubmed: 31851780
Curr Mol Med. 2015;15(9):873-81
pubmed: 26511703
Cell. 2007 Jun 15;129(6):1215-25
pubmed: 17574031
Cell Death Differ. 2021 Feb;28(2):799-813
pubmed: 33110215
Cell Discov. 2022 Apr 19;8(1):35
pubmed: 35436988
Cell Res. 2014 Nov;24(11):1288-98
pubmed: 25342558
Acta Cytol. 1998 Nov-Dec;42(6):1365-9
pubmed: 9850644
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16735-40
pubmed: 21933957
Cell Rep. 2020 Aug 25;32(8):108071
pubmed: 32846129
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Diagn Cytopathol. 2003 Feb;28(2):86-7
pubmed: 12561027
Cell Rep. 2017 Jul 5;20(1):201-210
pubmed: 28683313
Mod Pathol. 2020 Sep;33(9):1822-1831
pubmed: 32350415
Toxicol Appl Pharmacol. 2021 Feb 1;412:115353
pubmed: 33301752
PLoS Pathog. 2011 May;7(5):e1001338
pubmed: 21573183
Curr Mol Med. 2015;15(9):852-60
pubmed: 26511708
Cell Rep. 2019 Nov 5;29(6):1610-1620.e4
pubmed: 31693899
Cell Rep. 2019 Mar 19;26(12):3212-3220.e4
pubmed: 30893595
Sci Rep. 2017 Mar 14;7:44544
pubmed: 28291251
Cell. 2007 Nov 30;131(5):966-79
pubmed: 18045538
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):226-35
pubmed: 25051956
Front Immunol. 2021 Apr 19;12:662134
pubmed: 33953725
EMBO Mol Med. 2012 Sep;4(9):964-79
pubmed: 22821859
Cell Rep. 2015 Apr 21;11(3):358-65
pubmed: 25865893
Cancer Res. 2006 Apr 1;66(7):3629-38
pubmed: 16585188
Biochim Biophys Acta Mol Cell Res. 2018 Jun;1865(6):831-841
pubmed: 29548938
Radiat Oncol. 2017 Jan 18;12(1):21
pubmed: 28100275
Nat Cell Biol. 2011 Mar;13(3):324-30
pubmed: 21336303
Front Oncol. 2019 Sep 20;9:895
pubmed: 31681557
Cell Res. 2009 Dec;19(12):1350-62
pubmed: 19786985
Cytopathology. 2006 Oct;17(5):304-5
pubmed: 16961662
Front Oncol. 2020 Oct 15;10:541878
pubmed: 33178577
Cell. 1989 Feb 10;56(3):369-77
pubmed: 2464439
Cell Res. 2015 Nov;25(11):1265-8
pubmed: 26427717
Elife. 2017 Jul 11;6:
pubmed: 28693721

Auteurs

Qiao Chen (Q)

Department of Nutrition, Third Medical Center of PLA General Hospital, Beijing, China.

Xiaoning Wang (X)

National Clinic Center of Geriatric & the State Key Laboratory of Kidney, The Chinese PLA General Hospital, Beijing, China.

Meifang He (M)

Department of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH